Lallemand Inc’s subsidiary, Danstar Ferment AG, agreed to acquire the BASF Nutrilife® baking enzymes portfolio and business. The transaction is expected to complete on September 30, 2022. Having recently entered the field, Lallemand will broaden its enzyme portfolio and footprint with the acquisition.
“We look forward to continuing to provide Nutrilife® customers with enzyme expertise as well as access to innovative ingredients based on the Lallemand yeast and bacteria technology platforms,” said Lars Asferg, President of Lallemand Bio-Ingredients, in a joint statement with BASF.
“Baking enzymes is not a strategic fit for BASF. With Lallemand, we have found an excellent partner to strategically continue and strengthen our baking enzymes business and to be a reliable supplier. We will accompany the transaction to ensure a smooth handover for our customers,” added Michael de Marco, BASF’s Vice President, Global Business Management Enzymes.